Previous 10 | Next 10 |
A new whitepaper from BIONIK documents the positive clinical effects experienced by stroke patients with InMotion Therapy Robots BIONIK Laboratories Corp . (OTCQB:BNKL) ("BIONIK" or the "Company"), a robotics company focused on providing rehabilitation and assistive tech...
Bionik Laboratories press release (OTCQB:BNKL): Q3 Non-GAAP EPS of -$0.26. Revenue of $0.18M (+1.7% Y/Y). For further details see: Bionik Laboratories Non-GAAP EPS of -$0.26, revenue of $0.18M
Potential Sales Pipeline is Strongest in Corporate History BIONIK Laboratories Corp. (OTCQB: BNKL), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today...
Company to Showcase its InMotion ® Arm/Hand at the Country’s Largest Physical Therapy Conference from February 2-5, 2022 BIONIK Laboratories Corp. (OTCQB: BNKL) ("BIONIK" or the "Company"), a robotics company focused on providing rehabilitation and assist...
Company to Showcase its InMotion ® Robotic Therapy Systems at the World’s Largest Medical Industry Event BIONIK Laboratories Corp. (OTCQB: BNKL) (“BIONIK” or the “Company”), a robotics company focused on providing rehabilitatio...
Bionik Laboratories (OTCQB:BNKL): FQ2 Non-GAAP EPS of -$0.21; GAAP EPS of -$0.22. Revenue of $0.23M (-20.7% Y/Y) Press Release For further details see: Bionik Laboratories reports FQ2 results
$5 Million Capital Raise Strengthens Balance Sheet BIONIK Laboratories Corp. (OTCQB:BNKL), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today reported...
Company Placing Renewed Emphasis on the Country’s ‘Stroke Belt’, Increasing its Commitment to Address the Growing Needs of Stroke Patients BIONIK Laboratories Corp. (OTCQB: BNKL) ("BIONIK" or the "Company"), a robotics company focused on providin...
Company also reports three consecutive quarters of patient session growth as U.S. healthcare facilities continue to adopt innovative technologies to accelerate stroke recovery BIONIK Laboratories Corp . (OTCQB:BNKL) ("BIONIK" or the "Company"), a robotics company focused on ...
Revenues Increase 160% Over Same Period in Prior Year $5M Capital Raise to Convert at $9.50/Share Showing Confidence in Bionik BIONIK Laboratories Corp . (OTCQB:BNKL) , a robotics company focused on providing rehabilitation and assistive technology solutions ...
News, Short Squeeze, Breakout and More Instantly...
Bionik Laboratories Corp Company Name:
BNKL Stock Symbol:
OTCMKTS Market:
Bionik Laboratories Corp Website:
Klepierre (KLPEF) is expected to report for Q1 2024 Amerityre Corp (AMTY) is expected to report for Q3 2024 Gecina Nom. (GECFF) is expected to report for Q1 2024 Great Eagle Holdings Limited (GEAHF) is expected to report for Q1 2024 Babylon Holdings Limited Class A (BBLNF) is expe...
Amerityre Corp (AMTY) is expected to report for Q3 2024 CURO Group Holdings Corp. (CUROQ) is expected to report for Q1 2024 China Health Industries Holdings Inc (CHHE) is expected to report for Q3 2024 Avid Bioservices Inc. (CDMO) is expected to report $0.03 for Q4 2024 Anterix In...
Blue Ridge Real Estate Co. (BRRE) is expected to report for Q2 2024 Aravive Inc. (ARAV) is expected to report for Q1 2024 Biocept Inc. (BIOCQ) is expected to report for Q1 2024 Golden Matrix Group Inc. (GMGI) is expected to report for Q2 2024 Bluejay Diagnostics Inc. (BJDX) is exp...